Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 207 | 900 | 1,105 | 454 | 405 |
| Marketable Securities | 28 | 38 | 25 | N/A | N/A |
| Receivables | 37 | 12 | 41 | 87 | 34 |
| Inventories | 638 | 640 | 658 | 1,349 | 1,360 |
| Other current assets | 237 | 200 | 175 | 263 | 1,097 |
| TOTAL | $1,147 | $1,790 | $2,004 | $2,153 | $2,896 |
| Non-Current Assets | |||||
| PPE Net | 2,103 | 2,141 | 2,175 | 3,097 | 3,220 |
| Intangibles | 5,268 | 5,101 | 4,879 | 1,997 | 1,852 |
| Other Non-Current Assets | 667 | 680 | 685 | 696 | 779 |
| TOTAL | $8,038 | $7,922 | $7,739 | $5,790 | $5,851 |
| Total Assets | $9,185 | $9,712 | $9,743 | $7,943 | $8,747 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 726 | 180 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,255 | 1,014 | 628 | 933 | 883 |
| Accrued Expenses | 892 | 962 | 886 | 792 | 1,374 |
| TOTAL | $2,873 | $2,156 | $1,514 | $1,725 | $2,257 |
| Non-Current Liabilities | |||||
| Long Term Debt | 191 | 131 | 132 | 133 | 134 |
| Other Non-Current Liabilities | 0 | 2 | 5 | 7 | 26 |
| TOTAL | $191 | $133 | $137 | $140 | $160 |
| Total Liabilities | $3,064 | $2,289 | $1,651 | $1,865 | $2,417 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 100,091 | N/A | 92,868 | 90,809 | 83,892 |
| Common Shares | 139,122 | 138,014 | 135,774 | 131,920 | 130,570 |
| Retained earnings | -127,292 | -124,890 | -122,828 | -122,343 | -120,744 |
| Other shareholders' equity | -5,709 | -5,701 | -4,854 | -3,499 | -3,496 |
| TOTAL | $6,121 | $7,423 | $8,092 | $6,078 | $6,330 |
| Total Liabilities And Equity | $9,185 | $9,712 | $9,743 | $7,943 | $8,747 |